Cargando…
Novel Nanotherapeutics for Cancer Immunotherapy by PD-L1-Aptamer-Functionalized and Fexofenadine-Loaded Albumin Nanoparticles
Immune checkpoint blockade (ICB) is an important strategy for cancer treatment and has achieved remarkable clinical results. Further enhancement of the efficacy of ICB therapy with a new technical approach is of potential medical importance. In this study, we constructed a novel nanotherapeutic agen...
Autores principales: | Lai, Xialian, Yao, Fengjiao, An, Yacong, Li, Xundou, Yang, Xian-Da |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056566/ https://www.ncbi.nlm.nih.gov/pubmed/36985529 http://dx.doi.org/10.3390/molecules28062556 |
Ejemplares similares
-
Novel Complex of PD-L1 Aptamer and Albumin Enhances Antitumor Efficacy In Vivo
por: An, Yacong, et al.
Publicado: (2022) -
Novel Complex of PD-L1 Aptamer and Holliday Junction Enhances Antitumor Efficacy in Vivo
por: Li, Ting, et al.
Publicado: (2021) -
Targeted Therapy of Colon Cancer by Aptamer-Guided Holliday Junctions Loaded with Doxorubicin
por: Yao, Fengjiao, et al.
Publicado: (2020) -
Targeted Treatment of Colon Cancer with Aptamer-Guided Albumin Nanoparticles Loaded with Docetaxel
por: Yu, Zhen, et al.
Publicado: (2020) -
Selection of a novel DNA aptamer against OFA/iLRP for targeted delivery of doxorubicin to AML cells
por: An, Yacong, et al.
Publicado: (2019)